Javier Narvaez, PhD

Hospital Universitario de Bellvitge
Barcelona, Spain

Medical doctor

Presentation(s):

• 0642: Belimumab-Based Triple Therapy in Proliferative Lupus Nephritis: Renal Outcomes and Glucocorticoid Tapering in a Real-World Multicenter Cohort

  Sunday, October 26, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): No financial relationships with ineligible companies to disclose

• 0749: Prevalence and characteristics of subclinical Polymyalgia Rheumatica in patients with Giant Cell Arteritis

  Sunday, October 26, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): No financial relationships with ineligible companies to disclose

• 1162: Antineutrophil Cytoplasmic Antibody-associated Isolated Interstitial Lung Disease

  Monday, October 27, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): No financial relationships with ineligible companies to disclose

• 1161: Comparative efficacy, safety and tolerability of antifibrotic therapies across systemic autoimmune diseases

  Monday, October 27, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): No financial relationships with ineligible companies to disclose

• 2484: Phenotype of systemic sclerosis patients with positive anti–NOR-90 antibodies

  Tuesday, October 28, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): No financial relationships with ineligible companies to disclose

• 2485: Prevalence of progressive pulmonary fibrosis in systemic sclerosis-associated interstitial lung disease

  Tuesday, October 28, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): No financial relationships with ineligible companies to disclose